FindTrial
Sign In

To compare people with T2DM who have double hump versus who do not have double hump.

To compare people with T2DM who have double dorsal cervical fat (double hump) versus who do not have double dorsal cervical fat (double hump) - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/05/067816
Enrollment
200
Registered
2024-05-22
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E116- Type 2 diabetes mellitus with other specified complications

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

National Diabetes Obesity and Cholesterol Foundation
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: .Patients with T2DM (up to 30 years Duration) .BMI 25 to 40

Exclusion criteria

Exclusion criteria: .Alcoholic with Moderate to Severe. .BMI greater than 40 .Congestive heart disease .Positive hepatitis B or hepatitis C, secondary causes of fatty liver (eg. consumption of amiodarone and tamoxifen) and congestive hepatopathy. .Severe end organ damage or chronic diseases: renal/hepatic failure, any malignancy, major systemic illness etc.

Design outcomes

Primary

MeasureTime frame
Double Hump in people with T2D is associated with higher magnitude of diabetes-related complications than people with single hump or no humpTimepoint: 52 weeks—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactDr Anoop Misra

Fortis CDOC Hospital

anoopmisra@gmail.com01149101222

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026